| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 24.05.
| Myriad Genetics Crosses Above its 10-day MA | | - | SmarTrend |
| 23.05.
| 5-Star Stocks Poised to Pop: Myriad Genetics | | 2 | Motley Fool |
| 21.05.
| Intermountain Healthcare and Myriad Genetics Enter Into Research Collaboration Agreement | | 36 | PR Newswire |
| SALT LAKE CITY, May 21, 2012 /PRNewswire/ --Intermountain Healthcare and Myriad Genetics today announced they have signed a collaborative research agreement. The purpose of this agreement...
Mehr lesen zu:
Intermountain Healthcare and Myriad Genetics Enter Into Research Collaboration Agreement | |
| 19.05.
| Myriad Genetics' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) | | 3 | Seeking Alpha |
| 17.05.
| Bearish Moving Average Cross by Myriad Genetics | | 1 | SmarTrend |
| 14.05.
| Myriad Genetics Earnings Review: 13 Days after Announcement Shares Down 0.3% | | 2 | SmarTrend |
| 08.05.
| Myriad Genetics Up 18.2% Since SmarTrend Uptrend Call | | 4 | SmarTrend |
| 02.05.
| Recent 52-Week High Exceeded in Shares of Myriad Genetics | | 4 | SmarTrend |
| 02.05.
| MYRIAD GENETICS INC - 10-Q, Quarterly Report | | 6 | SEC Filings |
| 02.05.
| Myriad Genetics' CEO Discusses Q1 2012 Results - Earnings Call Transcript | | 4 | Seeking Alpha |
| 01.05.
| Myriad Genetics Q3 Profit Up, Tops View; Lifts FY Outlook; Stock Up 2.5% | | 44 | AFX News |
| WASHINGTON (dpa-AFX) - Molecular diagnostic company Myriad Genetics Inc.
(MYGN) Tuesday reported third-quarter net income of $29.6 million or $0.34 per
share, compared to $28 million or...
Mehr lesen zu:
Myriad Genetics Q3 Profit Up, Tops View; Lifts FY Outlook; Stock Up 2.5% | |
| 27.04.
| Shares of Myriad Genetics Has Risen Above Previous 52-Week High | | 2 | SmarTrend |
| 26.04.
| Watch for Continued Gains in Shares of Myriad Genetics | | 2 | SmarTrend |
| 23.04.
| Myriad Genetics Has Returned 16.0% Since SmarTrend Recommendation | | 4 | SmarTrend |
| 20.04.
| Upgrade Alert for Myriad Genetics | | 14 | SmarTrend |
| 20.04.
| Myriad Genetics has the Lowest EPS Growth in the Biotechnology Industry | | 12 | SmarTrend |
| 30.03.
| Myriad Genetics Study Finds High Prevalence Of Mutations In The PMS2 Gene | | 60 | AFX News |
| WASHINGTON (dpa-AFX) - Myriad Genetics Inc. (MYGN) announced that a
presentation entitled, 'Representation of PMS2 mutations in patients seeking
genetic testing for Lynch syndrome,' was...
Mehr lesen zu:
Myriad Genetics Study Finds High Prevalence Of Mutations In The PMS2 Gene | |
| 29.03.
| Myriad And Cephalon Enter Into Companion Diagnostic Deal | | 69 | AFX News |
| PETAH TIKVA (dpa-AFX) - Myriad Genetics, Inc. (MYGN) announced that it has
signed an agreement with Cephalon Inc., a subsidiary of Teva Pharmaceutical
Industries Ltd Company, to conduct...
Mehr lesen zu:
Myriad And Cephalon Enter Into Companion Diagnostic Deal | |
| 26.03.
| Myriad Genetics Says Supreme Court Of United States Remands Gene Patenting Case | | 63 | AFX News |
| WASHINGTON (dpa-AFX) - Myriad Genetics Inc. (MYGN) announced that the
Supreme Court of the United States remanded the case of The Association for
Molecular Pathology, et al., v. Myriad Genetics...
Mehr lesen zu:
Myriad Genetics Says Supreme Court Of United States Remands Gene Patenting Case | |
| 24.02.
| Myriad Genetics' (MYGN) Prolaris Shown to Predict Prostate Cancer Outcome | | 5 | StreetInsider.com |
